Huei-Ju Ting, Ph.D.

Affiliations: 
2002 University of Rochester, Rochester, NY 
Area:
Molecular Biology, Oncology
Google:
"Huei-Ju Ting"
Mean distance: 10177.7
 

Parents

Sign in to add mentor
Chawnshang Chang grad student 2002 Rochester
 (The cloning and characterization of androgen receptor coregulators, supervillin and gelsolin.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Hu YC, Yeh S, Yeh SD, et al. (2020) Correction: Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer. The Journal of Biological Chemistry. 295: 17382
Altuwaijri S, Lee DK, Chuang KH, et al. (2020) Correction to: Androgen receptor regulates expression of skeletal muscle-specific proteins and muscle cell types. Endocrine
Lai GR, Lee YF, Yan SJ, et al. (2020) Active vitamin D induced gene-specific hypomethylation in prostate cancer cells developing vitamin D resistance. American Journal of Physiology. Cell Physiology
Lin VC, Huang SP, Ting HJ, et al. (2017) Vitamin D receptor-binding site variants affect prostate cancer progression. Oncotarget. 8: 74119-74128
Hsu CL, Liu JS, Lin TW, et al. (2017) Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening. Oncotarget. 8: 69508-69519
Lin VC, Huang SP, Ting HJ, et al. (2017) Vitamin D receptor-binding site variants affect prostate cancer progression. Oncotarget
Hsu CL, Liu JS, Lin TW, et al. (2017) Characterization of a novel androgen receptor (AR) coregulator RIPK1 and related chemicals that suppress AR-mediated prostate cancer growth via peptide and chemical screening. Oncotarget
Hsu CL, Liu JS, Wu PL, et al. (2014) Identification of a new androgen receptor (AR) co-regulator BUD31 and related peptides to suppress wild-type and mutated AR-mediated prostate cancer growth via peptide screening and X-ray structure analysis. Molecular Oncology. 8: 1575-87
Beckham CJ, Olsen J, Yin PN, et al. (2014) Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression. The Journal of Urology. 192: 583-92
Ting HJ, Messing J, Yasmin-Karim S, et al. (2013) Identification of microRNA-98 as a therapeutic target inhibiting prostate cancer growth and a biomarker induced by vitamin D. The Journal of Biological Chemistry. 288: 1-9
See more...